Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 11, 2001, Pages 3056-3058

  Klein, J L ^a   Brown, T J ^a   French, G L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GENE PRODUCT; RIFAMPICIN; RNA POLYMERASE; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BETA CHAIN; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; MISSENSE MUTATION; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTIBIOTICS, ANTITUBERCULAR; BASE SEQUENCE; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM KANSASII; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIFAMPIN;

EID: 0034780434     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.11.3056-3058.2001     Document Type: Article

References (19)

1. Susceptibility testing of mycobacteria
2. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii
3. Physiological cost or rifampin resistance induced in vitro in Mycobacterium tuberculosis
4. Mutation position and type of substitution in the β subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis
5. Acquired resistance to rifampicin by Mycobacterium kansasii
6. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium kansasii
7. Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare
8. Molecular basis of rifampin resistance in Mycobacterium leprae
9. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB)
10. Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv
11. The epidemiology of nontuberculous mycobacterial diseases in the United States
12. Treatment of pulmonary disease due to Mycobacterium kansasii: Recent experience with rifampin
13. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 Update
14. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
15. Rifampin-resistant Mycobacterium kansasii
16. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampicin, and streptomycin by using Etest
17. Contribution of mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis
18. Characterization of rifampin resistance in pathogenic mycobacteria
19. Sensitivity of opportunist mycobacteria to rifampicin and ethambutol